Daily drug taken by millions found to increase risk of dementia by 33%

Proton pump inhibitors (PPIs)—a class of medication including Omeprazole, Lansoprazole, and Pantoprazole—are widely used globally to manage acid reflux and heartburn by suppressing stomach acid production. In the UK alone, there were 35 million Omeprazole prescriptions issued between 2022 and 2023. While these drugs are typically intended for short-term use of four to eight weeks, their widespread and often long-term application has drawn new scrutiny from the medical community regarding potential neurological risks.

Did You Know? Doctors typically prescribe PPIs for a duration of only four to eight weeks, as extended use is linked to a variety of side effects, including weakened bones, rare forms of lupus, and depleted vitamin B12 levels.

The Association Between PPIs and Dementia

A 2023 study has highlighted a concerning potential link between the long-term use of PPIs and an increased risk of dementia. Researchers led by Dr. Kamakshi Lakshminarayan analysed 5,712 participants aged 45 to 64 who were dementia-free at the start of the investigation. Among the 497 participants who consumed PPIs for nearly four and a half years, 58 individuals eventually developed dementia.

The data suggests that individuals taking these medications over a long period were 33 percent more likely to develop the condition. However, researchers emphasize that this study identifies an association rather than a definitive causal link. More research is required to confirm these findings across larger, diverse populations.

Biological Mechanisms and Expert Interpretation

Experts are currently investigating why such an association might exist. One theory involves vitamin B12 deficiency. prolonged PPI use can lead to low B12 levels, which are associated with impaired thinking and memory. While Dr. Lakshminarayan noted she could not verify this theory without specific B12 measurements from her study group, other experts have proposed different biological pathways.

Expert Insight: The potential for PPIs to interact with brain chemistry represents a significant medical consideration. Dr. Gregory Day of the Mayo Clinic suggests that these drugs may alter enzymes responsible for managing amyloid proteins in the brain. Since amyloid accumulation is a hallmark of Alzheimer’s disease, the primary cause of dementia, this mechanism offers a plausible, though theoretical, explanation for the observed association.

What May Happen Next

As the medical community continues to analyze these findings, it is likely that physicians will place increased emphasis on the necessity of short-term PPI protocols. Future clinical research may prioritize measuring B12 levels and tracking amyloid protein changes in patients who require long-term acid reflux management.

Patients currently relying on these medications might see a shift toward alternative management strategies, such as dietary adjustments, weight maintenance, and the use of antacids. However, medical professionals stress that patients should not stop taking prescribed PPIs abruptly, as doing so may lead to a worsening of reflux symptoms. Any change to a treatment regimen should be conducted in close consultation with a healthcare provider.

Frequently Asked Questions

Does this study prove that PPIs cause dementia?
No. The study identifies an association between long-term PPI use and a higher risk of dementia, but it does not establish a direct causal link. Further research is necessary to confirm these findings.

Are there side effects to using PPIs long-term?
Yes. Long-term use is associated with several risks, including low vitamin B12 levels, weakened bones, kidney disease, stroke, and a rare form of lupus that causes joint pain and skin rashes.

Should I stop taking my acid reflux medication immediately?
No. It is important to speak with your doctor before making any changes. Stopping these medications abruptly can result in worse symptoms, and a doctor can help determine the best treatment plan for your specific health needs.

Have you discussed the long-term risks and benefits of your current medication regimen with your healthcare provider?